See more : Ray Co., Ltd. (228670.KQ) Income Statement Analysis – Financial Results
Complete financial analysis of DD3 Acquisition Corp. II (DDMXU) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of DD3 Acquisition Corp. II, a leading company in the Shell Companies industry within the Financial Services sector.
You may be interested
- Raymond James Financial, Inc. (RJF) Income Statement Analysis – Financial Results
- G3 Exploration Limited (G3E.L) Income Statement Analysis – Financial Results
- K. Wah International Holdings Limited (0173.HK) Income Statement Analysis – Financial Results
- Inception Growth Acquisition Limited (IGTAR) Income Statement Analysis – Financial Results
- Mazda Motor Corporation (MZDAF) Income Statement Analysis – Financial Results
DD3 Acquisition Corp. II (DDMXU)
| Metric | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Revenue | 115.75M | 80.25M | 70.50M | 61.58M |
| Cost of Revenue | 4.84M | 4.02M | 4.26M | 32.52M |
| Gross Profit | 110.90M | 76.23M | 66.24M | 29.06M |
| Gross Profit Ratio | 95.82% | 94.99% | 93.96% | 47.19% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 65.22M | 43.58M | 5.16M | 31.91M |
| Selling & Marketing | 88.41M | 48.21M | 35.06M | 34.43M |
| SG&A | 153.64M | 91.80M | 5.16M | 66.34M |
| Other Expenses | 13.14M | 13.98M | 79.59M | 11.12M |
| Operating Expenses | 166.78M | 105.77M | 84.75M | 77.46M |
| Cost & Expenses | 171.62M | 105.77M | 84.75M | 77.46M |
| Interest Income | 25.10M | 4.54M | 168.00K | 194.00K |
| Interest Expense | 12.64M | 561.00K | 520.00K | 269.00K |
| Depreciation & Amortization | 556.00K | 721.00K | 868.34K | 1.19M |
| EBITDA | -54.95M | -65.77M | -13.15M | -14.68M |
| EBITDA Ratio | -47.48% | -25.24% | -18.89% | -23.84% |
| Operating Income | -55.88M | -71.03M | -86.25M | -15.88M |
| Operating Income Ratio | -48.27% | -88.51% | -122.34% | -25.78% |
| Total Other Income/Expenses | 12.46M | -41.42M | -520.00K | -269.00K |
| Income Before Tax | -43.42M | -67.05M | -14.77M | -16.15M |
| Income Before Tax Ratio | -37.51% | -83.54% | -20.95% | -26.22% |
| Income Tax Expense | 2.97M | 966.00K | 1.51M | -53.00K |
| Net Income | -46.38M | -68.01M | -16.28M | -16.09M |
| Net Income Ratio | -40.07% | -84.75% | -23.09% | -26.13% |
| EPS | -1.03 | -10.17 | -0.33 | -0.32 |
| EPS Diluted | -1.03 | -10.17 | -0.33 | -0.32 |
| Weighted Avg Shares Out | 45.12M | 6.69M | 49.72M | 49.72M |
| Weighted Avg Shares Out (Dil) | 45.12M | 6.69M | 49.72M | 49.72M |
DD3 Acquisition Corp. II Receives Expected Notice from Nasdaq Regarding Delayed Quarterly Report
MEXICO CITY, June 03, 2021 (GLOBE NEWSWIRE) -- DD3 Acquisition Corp. II (Nasdaq: DDMX) (the “Company”) today announced that it received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the...
DD3 Acquisition Corp. II Announces the Separate Trading of Its Class A Common Stock and Warrants Commencing on or About January 27, 2021
MEXICO CITY, Jan. 26, 2021 (GLOBE NEWSWIRE) -- DD3 Acquisition Corp. II (the “Company”), today announced that holders of the units sold in the Company's initial public offering of 12,500,000 units completed on December 10, 2020 (the “offering”) may elect...
U.S. IPO Weekly Recap: Breast Cancer Biotech Pops 158% In A 6-IPO Week
In a scramble to go public ahead of the holiday, six IPOs and 15 SPACs went public this past week led by breast cancer biotech Olema Pharmaceuticals, which soared 158% on its first day. New filings continued to pour in,...
Source: https://incomestatements.info
Category: Stock Reports